Current Problems in Surgery
Volume 45, Issue 6 , Pages 388-439 , June 2008

Incidental Findings at Surgery—Part 2

  • Frank J. Schaberg Jr, MD

      Affiliations

    • Associate Professor of Surgery (Clinical), Warren Alpert School of Medicine at Brown University, Providence, Rhode Island
    • ,
  • Richard A. Prinz, MD

      Affiliations

    • Helen Shedd Keith Professor, Chairman, Department of General Surgery, Rush University, Chicago, Illinois
    • ,
  • Emery L. Chen, MD

      Affiliations

    • Attending Surgeon, Woodland Clinic, Woodland, California
    • ,
  • Aileen Caceres, MD, MPH

      Affiliations

    • Clinical Research Fellow, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Dennis S. Chi, MD

      Affiliations

    • Associate Attending Surgeon, Memorial Sloan-Kettering Cancer Center, New York, New York
    • ,
  • Beth A. Ryder, MD

      Affiliations

    • Clinical Assistant Professor of Surgery, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island
    • ,
  • Thomas Ng, MD

      Affiliations

    • Assistant Professor of Surgery, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island
    • ,
  • Maurizio Santi Aragona, MD

      Affiliations

    • Resident in Training, University of Padua, Padua, Italy
    • ,
  • Chad Wotkowicz, MD

      Affiliations

    • Senior Resident in Urology, Lahey Clinic, Burlington, Massachusetts
    • ,
  • John A. Libertino, MD

      Affiliations

    • Chairman of Urology, Lahey Clinic, Burlington, Massachusetts

References 

  1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–142
  2. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules (Final report of a 15-year study of the incidence of thyroid malignancy). Ann Intern Med. 1968;69:537–540
  3. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas (Prevalence by palpation and ultrasonography). Arch Intern Med. 1994;154:1838–1840
  4. Tan GH, Gharib H, Reading CC. Solitary thyroid nodule (Comparison between palpation and ultrasonography). Arch Intern Med. 1995;155:2418–2423
  5. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 1955;15:1270–1280
  6. Carroll BA. Asymptomatic thyroid nodules: incidental sonographic detection. AJR Am J Roentgenol. 1982;138:499–501
  7. Milas M, Mensah A, Alghoul M, Berber E, Stephen A, Siperstein A, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid. 2005;15:1055–1059
  8. Tomimori E, Pedrinola F, Cavaliere H, Knobel M, Medeiros-Neto G. Prevalence of incidental thyroid disease in a relatively low iodine intake area. Thyroid. 1995;5:273–276
  9. Bartolotta TV, Midiri M, Runza G, Galia M, Taibbi A, Damiani L, et al. Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler pattern in an adult population screened by real-time compound spatial sonography. Radiol Med (Torino). 2006;111:989–998
  10. Yousem DM, Huang T, Loevner LA, Langlotz CP. Clinical and economic impact of incidental thyroid lesions found with CT and MR. AJNR Am J Neuroradiol. 1997;18:1423–1428
  11. Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609–615
  12. Khafagi F, Wright G, Castles H, Perry-Keene D, Mortimer R. Screening for thyroid malignancy: the role of fine-needle biopsy. Med J Aust. 1988;149:302–303306-7
  13. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al. CM (Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features). J Clin Endocrinol Metab. 2002;87:1941–1946
  14. Leenhardt L, Hejblum G, Franc B, Fediaevsky LD, Delbot T, Le Guillouzic D, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab. 1999;84:24–28
  15. Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004;60:21–28
  16. Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf). 2004;60:719–725
  17. Mandel SJ. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract. 2004;10:246–252
  18. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112:1139–1146discussion 1146-7
  19. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879–885
  20. Fujimoto Y, Sugitani I. Postoperative prognosis of intrathyroidal papillary thyroid carcinoma: long-term (35-45 year) follow-up study. Endocr J. 1998;45:475–484
  21. AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract. 2006;12:63–102
  22. Ito Y, Miyauchi A. A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab. 2007;3:240–248
  23. Argenta PA, Nezhat F. Approaching the adnexal mass in the new millennium. J Am Assoc Gynecol Laparosc. 2000;7:455–471
  24. Borgfeldt C, Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol. 1999;13:345–350
  25. Castillo G, Alcazar JL, Jurado M. Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol. 2004;92:965–969
  26. Gonzalez R, Haines K, Gallagher SF, Sanders G, Hoffman M, Murr MM. Management of incidental ovarian tumors in patients undergoing gastric bypass. Obes Surg. 2004;14:1216–1221
  27. Leng JH, Lang JH, Zhang JJ, Feng FZ, Liu ZF, Sun DW, et al. Role of laparoscopy in the diagnosis and treatment of adnexal masses. Chin Med J (Engl). 2006;119:202–206
  28. Bristow RE, Nugent AC, Zahurak ML, Khouzhami V, Fox HE. Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass. J Adolesc Health. 2006;39:411–416
  29. Ding DC, Chen SS. Conservative laparoscopic management of ovarian teratoma torsion in a young woman. J Chin Med Assoc. 2005;68:37–39
  30. Dottino PR, Levine DA, Ripley DL, Cohen CJ. Laparoscopic management of adnexal masses in premenopausal and postmenopausal women. Obstet Gynecol. 1999;93:223–228
  31. Giuntoli RL, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006;49:492–505
  32. Pados G, Tsolakidis D, Bontis J. Laparoscopic management of the adnexal mass. Ann N Y Acad Sci. 2006;1092:211–228
  33. Bennington JL, Ferguson BR, Haber SL. Incidence and relative frequency of benign and malignant ovarian neoplasms. Obstet Gynecol. 1968;32:627–632
  34. Raiga J, Djafer R, Benoit B, Treisser A. [Management of ovarian cysts]. J Chir (Paris). 2006;143:278–284
  35. Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril. 1995;63:439–463
  36. Fanfani F, Fagotti A, Longo R, Marana E, Mancuso S, Scambia G. Minilaparotomy in the management of benign gynecologic disease. Eur J Obstet Gynecol Reprod Biol. 2005;119:232–236
  37. Berek JS. Epithelial ovarian cancer. In:  Berek JS,  Hacker NF editor. Practical Gynecologic Oncology. 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 451
  38. Killackey MA, Neuwirth RS. Evaluation and management of the pelvic mass: a review of 540 cases. Obstet Gynecol. 1988;71(3 Pt 1):319–322
  39. Herbst A. Neoplastic diseases of the uterus. In:  Manning S,  Steinborn E,  Salway J editor. Comprehensive Gynecology. St. Louis: Mosby-Year Book, Inc; 1992;p. 924
  40. Leiserowitz GS, Xing G, Cress R, Brahmbhatt B, Dalrymple JL, Smith LH. Adnexal masses in pregnancy: how often are they malignant?. Gynecol Oncol. 2006;101:315–321
  41. Norris HJ, Jensen RD. Relative frequency of ovarian neoplasms in children and adolescents. Cancer. 1972;30:713–719
  42. Shawis RN, El Gohary A, Cook RC. Ovarian cysts and tumours in infancy and childhood. Ann R Coll Surg Engl. 1985;67:17–19
  43. Wolf SI, Gosink BB, Feldesman MR, Lin MC, Stuenkel CA, Braly PS, et al. Prevalence of simple adnexal cysts in postmenopausal women. Radiology. 1991;180:65–71
  44. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol. 2004;93:87–91
  45. Juretzka MM, Crawford CL, Lee C, Wilton A, Schuman S, Chi DS, et al. Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy. Gynecol Oncol. 2006;101:327–330
  46. Curtin JP. Management of the adnexal mass. Gynecol Oncol. 1994;55(3 Pt 2):S42–S46
  47. Chi DS, Curtin JP, Barakat RR. Laparoscopic management of adnexal masses in women with a history of nongynecologic malignancy. Obstet Gynecol. 1995;86:964–968
  48. Goldstein SR, Subramnyam B, Snyder JR, Beller U, Raghavendra BN, Beckman EM. The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative management. Obstet Gynecol. 1989;73:8–10
  49. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P Writing Committee Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004;126:114–121
  50. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354:99–105
  51. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002;165:508–513
  52. Winer-Muram HT. The solitary pulmonary nodule. Radiology. 2006;239:34–49
  53. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis (Part I). Theor Radiol. 1993;186:405–413
  54. Libby DM, Smith JP, Altorki NK, Pasmantier MW, Yankelevitz D, Henschke CI. Managing the small pulmonary nodule discovered by CT. Chest. 2004;125:1522–1529
  55. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914–924
  56. Swensen SJ, Brown LR, Colby TV, Weaver AL, Midthun DE. Lung nodule enhancement at CT: prospective findings. Radiology. 1996;201:447–455
  57. Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology. 1991;179:469–476
  58. Siegelman SS, Khouri NF, Leo FP, Fishman EK, Braverman RM, Zerhouni EA. Solitary pulmonary nodules: CT assessment. Radiology. 1986;160:307–312
  59. Zerhouni EA, Stitik FP, Siegelman SS, Naidich DP, Sagel SS, Proto AV, et al. CT of the pulmonary nodule: a cooperative study. Radiology. 1986;160:319–327
  60. Woodring JH, Fried AM. Significance of wall thickness in solitary cavities of the lung: a follow-up study. AJR Am J Roentgenol. 1983;140:473–474
  61. Kui M, Templeton PA, White CS, Cai ZL, Bai YX, Cai YQ. Evaluation of the air bronchogram sign on CT in solitary pulmonary lesions. J Comput Assist Tomogr. 1996;20:983–986
  62. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS LCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002;178:1053–1057
  63. Yankelevitz DF, Henschke CI. Does 2-year stability imply that pulmonary nodules are benign?. AJR Am J Roentgenol. 1997;168:325–328
  64. Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology. 1962;79:221–232
  65. Jennings SG, Winer-Muram HT, Tarver RD, Farber MO. Lung tumor growth: assessment with CT—comparison of diameter and cross-sectional area with volume measurements. Radiology. 2004;231:866–871
  66. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology. 2000;217:251–256
  67. Naidich DP, Sussman R, Kutcher WL, Aranda CP, Garay SM, Ettenger NA. Solitary pulmonary nodules (CT-bronchoscopic correlation). Chest. 1988;93:595–598
  68. Gaeta M, Barone M, Russi EG, Volta S, Casablanca G, Romeo P, et al. Carcinomatous solitary pulmonary nodules: evaluation of the tumor-bronchi relationship with thin-section CT. Radiology. 1993;187:535–539
  69. Mehta AC, Kathawalla SA, Chan C, Arroliga A. Role of bronchoscopy in the evaluation of solitary pulmonary nodule. J Bronchol. 1995;2:315–322
  70. Lacasse Y, Wong E, Guyatt GH, Cook DJ. Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis. Thorax. 1999;54:884–893
  71. Wallace MJ, Krishnamurthy S, Broemeling LD, Gupta S, Ahrar K, Morello FA, et al. CT-guided percutaneous fine-needle aspiration biopsy of small (< or = 1-cm) pulmonary lesions. Radiology. 2002;225:823–828
  72. Santambrogio L, Nosotti M, Bellaviti N, Pavoni G, Radice F, Caputo V. CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation. Chest. 1997;112:423–425
  73. Boiselle PM, Shepard JA, Mark EJ, Szyfelbein WM, Fan CM, Slanetz PJ, et al. Routine addition of an automated biopsy device to fine-needle aspiration of the lung: a prospective assessment. AJR Am J Roentgenol. 1997;169:661–666
  74. Mack MJ, Hazelrigg SR, Landreneau RJ, Acuff TE. Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg. 1993;56:825–830
  75. Cardillo G, Regal M, Sera F, Di Martino M, Carbone L, Facciolo F, et al. Videothoracoscopic management of the solitary pulmonary nodule: a single-institution study on 429 cases. Ann Thorac Surg. 2003;75:1607–1611
  76. Suzuki K, Nagai K, Yoshida J, Ohmatsu H, Takahashi K, Nishimura M, et al. Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking. Chest. 1999;115:563–568
  77. Powell TI, Jangra D, Clifton JC, Lara-Guerra H, Church N, English J, et al. Peripheral lung nodules: fluoroscopically guided video-assisted thoracoscopic resection after computed tomography-guided localization using platinum microcoils. Ann Surg. 2004;240:481–488
  78. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules (Application to small radiologically indeterminate nodules). Arch Intern Med. 1997;157:849–855
  79. Swensen SJ, Silverstein MD, Edell ES, Trastek VF, Aughenbaugh GL, Ilstrup DM, et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc. 1999;74:319–329
  80. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology. 1993;186:415–422
  81. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest. 1997;112:416–422
  82. Kondo D, Yamada K, Kitayama Y, Hoshi S. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg. 2003;76:350–355
  83. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 2005;129:87–93
  84. Lee PC, Korst RJ, Port JL, Kerem Y, Kansler AL, Altorki NK. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. J Thorac Cardiovasc Surg. 2006;132:1382–1389
  85. Simon G, Ginsberg RJ, Ruckdeschel JC. Small-cell lung cancer. Chest Surg Clin N Am. 2001;11:165–188
  86. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer (Lung Cancer Study Group). Ann Thorac Surg. 1995;60:615–622
  87. McKenna RJ, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg. 2006;81:421–425
  88. Ng T, Ryder BA. Evolution to video-assisted thoracic surgery lobectomy after training: initial results of the first 30 patients. J Am Coll Surg. 2006;203:551–557
  89. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176:2353–2358
  90. Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C. Prognostic significance of incidental renal cell carcinoma. Eur Urol. 1995;27:319–323
  91. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203–205
  92. Shintaku I, Suzuki Y, Uchi K, Morita M, Terasawa Y. [Characteristics of incidentally detected renal cell carcinoma by ultrasonography at health check-up]. Nippon Hinyokika Gakkai Zasshi. 2000;91:43–48
  93. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer. 2004;100:738–745
  94. Volpe A, Jewett MA. The natural history of small renal masses. Nat Clin Pract Urol. 2005;2:384–390
  95. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 2000;163:1090–1095quiz 1295
  96. Patard JJ, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B. Prognostic significance of the mode of detection in renal tumours. BJU Int. 2002;90:358–363
  97. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology. 2000;56:58–62
  98. Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, De La Taille A, et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol. 2004;172:858–862
  99. Patard JJ, Dorey FJ, Cindolo L, Ficarra V, De La Taille A, Tostain J, et al. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol. 2004;172:2167–2171
  100. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–2220
  101. Hellsten S, Johnsen J, Berge T, Linell F. Clinically unrecognized renal cell carcinoma (Diagnostic and pathological aspects). Eur Urol. 1990;18(Suppl 2):2–3
  102. Zhang J, Lefkowitz RA, Bach A. Imaging of kidney cancer. Radiol Clin North Am. 2007;45:119–147
  103. Israel GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin North Am. 2003;30:499–514
  104. Ho VB, Allen SF, Hood MN, Choyke PL. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology. 2002;224:695–700
  105. Coll DM, Smith RC. Update on radiological imaging of renal cell carcinoma. BJU Int. 2007;99:1217–1222
  106. Wotkowicz C, Libertino JA. Renal cell cancer: radical nephrectomy. BJU Int. 2007;99:1231–1238
  107. Campbell MF, Wein AJ, Kavoussi LR. Campbell-Walsh Urology. Vol. 2. Philadelphia: Saunders Elsevier; 2007:1567-630.
  108. Terada N, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, Arai Y. The natural history of simple renal cysts. J Urol. 2002;167:21–23
  109. Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol. 1997;157:1852–1853
  110. Renshaw AA. Subclassification of renal cell neoplasms: an update for the practising pathologist. Histopathology. 2002;41:283–300
  111. Chao DH, Zisman A, Pantuck AJ, Freedland SJ, Said JW, Belldegrun AS. Changing concepts in the management of renal oncocytoma. Urology. 2002;59:635–642
  112. Siu W, Hafez KS, Johnston WK, Wolf JS. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol. 2007;25:115–119
  113. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168:1315–1325
  114. Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol. 1986;135:1121–1124
  115. Volpe A, Kachura JR, Geddie WR, Evans AJ, Gharajeh A, Saravanan A, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol. 2007;178:379–386
  116. Wood BJ, Khan MA, McGovern F, Harisinghani M, Hahn PF, Mueller PR. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol. 1999;161:1470–1474
  117. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004;171:1802–1805
  118. Remzi M, Ozsoy M, Klingler HC, Susani M, Waldert M, Seitz C, et al. Are small renal tumors harmless? (Analysis of histopathological features according to tumors 4 cm or less in diameter). J Urol. 2006;176:896–899
  119. Crispen PL, Uzzo RG. The natural history of untreated renal masses. BJU Int. 2007;99:1203–1207
  120. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–431
  121. Kato M, Suzuki T, Suzuki Y, Terasawa Y, Sasano H, Arai Y. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol. 2004;172:863–866
  122. Oda T, Miyao N, Takahashi A, Yanase M, Masumori N, Itoh N, et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol. 2001;8:473–477
  123. Volpe A, Jewett MA. The role of surveillance for small renal masses. Nat Clin Pract Urol. 2007;4:2–3
  124. Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol. 1999;161:33–34discussion 34-5
  125. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163:442–445
  126. Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006;175:2027–2031
  127. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001;166:6–18
  128. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75:1236–1242
  129. Clark PE, Schover LR, Uzzo RG, Hafez KS, Rybicki LA, Novick AC. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology. 2001;57:252–256
  130. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol. 2000;163:730–736
  131. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999;162:1930–1933
  132. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol. 2004;171:1066–1070
  133. Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stockle M. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol. 2006;49:1058–1063discussion 1063-4
  134. Campbell SC, Novick AC. Expanding the indications for elective partial nephrectomy: is this advisable?. Eur Urol. 2006;49:952–954
  135. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?. Urology. 2006;67:254–259
  136. Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Columbo JR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178:41–46
  137. Desai MM, Strzempkowski B, Matin SF, Steinberg AP, Ng C, Meraney AM, et al. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol. 2005;173:38–41
  138. Portis AJ, Yan Y, Landman J, Chen C, Barrett PH, Fentie DD, et al. Long-term followup after laparoscopic radical nephrectomy. J Urol. 2002;167:1257–1262
  139. Chan DY, Cadeddu JA, Jarrett TW, Marshall FF, Kavoussi LR. Laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. J Urol. 2001;166:2095–2099discussion 2099-100
  140. Stein RJ, Kaouk JH. Renal cryotherapy: a detailed review including a 5-year follow-up. BJU Int. 2007;99:1265–1270
  141. Aron M, Gill IS. Renal tumor ablation. Curr Opin Urol. 2005;15:298–305
  142. Hegarty NJ, Kaouk JH, Remer EM, et al. Laparoscopic renal cryoablation: oncological outcomes at 5 years. [abstract] J Endourol. 2006;20(Suppl 1):A12
  143. Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006;68:2–6
  144. Park S, Cadeddu JA, Shingleton WB. Oncologic outcomes for ablative therapy of kidney cancer. Curr Urol Rep. 2007;8:31–37
  145. Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006;68:7–13
  146. Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ, et al. Renal cell carcinoma guideline. Eur Urol. 2007;51:1502–1510

PII: S0011-3840(08)00027-0

doi: 10.1067/j.cpsurg.2008.02.002

Current Problems in Surgery
Volume 45, Issue 6 , Pages 388-439 , June 2008

Article Tools

* Image Usage & Resolution